Close menu




April 12th, 2022 | 18:27 CEST

Ukraine: K+S, Bayer, Ximen Mining - Fertilizer shares against the food disaster!

  • PreciousMetals
  • Agriculture
Photo credits: pixabay.com

Ukraine is one of the leading export nations of wheat worldwide. However, the so-called "granary of Europe" does not primarily supply European countries because the main customers are mainly in Asia and North Africa. The most important destination for Ukrainian wheat in 2020, for example, was Egypt. The largest amount is transported overland to Odessa, where it is shipped. But now Putin has started bombing the important port city. Diesel and fertilizer are becoming scarce, so it is all the more important that there are Western specialists who are trying to secure a supply of food through special deliveries in fertilizer and technology. Where are the opportunities for investors?

time to read: 4 minutes | Author: André Will-Laudien
ISIN: K+S AG NA O.N. | DE000KSAG888 , BAYER AG NA O.N. | DE000BAY0017 , XIMEN MINING | CA98420B2003

Table of contents:


    Ukraine conflict - Food shortages ahead

    The price of wheat reached a new high of around USD 420 per ton in March. The main reason for this is the Russian invasion of Ukraine, the leading producer country. Currently, the "granary of Europe" can no longer sell its export hit. Farmers are sitting on thousands of tons of the last harvest and are only mobile at the risk of their lives. A dramatic supply shortage and subsequent famine, especially in Africa, could be the medium-term consequence. Therefore, the international community is called upon to recultivate land set aside from years of surplus production. Technical equipment and fertilizer are needed for this.

    K+S - The fertilizer rally continues

    The MDAX stock Kali und Salz (K+S) is currently in the front line. In addition to road salt for the expiring winter, the Company produces enormous quantities of potash and phosphorus fertilizers. With the start of the warlike activities, concerns about food producers in the war zones were transferred to direct price gains in the K+S share.

    Now the analysts' buy studies are also piling up. The group from Kassel is benefiting from the high energy prices in the overall good agar environment, said JP Morgan expert Chetan Udeshi in a current sector study. Despite the strong price development of +100% in 2022, he raised his investment recommendation by two notches from "underweight" to "overweight" and increased the target price from EUR 12.50 to EUR 44.50. That leaves the share price little choice but to continue to explode. In the last month alone, it went up by a cumulative 35%.

    Massive supply problems for fertilizers following sanctions against Russia are leading to a real boost in earnings for the potash producer this year. And the environment for Europe's fertilizer producers is likely to remain very positive for the next 2 years, as potash prices are now expected to remain high for a longer period. In addition to Ukraine, the world is also looking at the sanctions that have been imposed on Belarus. Both states have accounted for large quantities of global production of potash, ammonia and urea to date.

    The strong trend in the K+S share continues to argue in favor of a long position. Meanwhile, the woes of some short-sellers are also likely to lead to a huge turnover. The fundamental trend is thus continuing upwards. Presumably, K+S is now experiencing two special profit years. Therefore, the trick will be to recognize the upper turning point in time after the Ukraine crisis.

    Ximen Mining - Gold could provide the next refuge

    If, in addition, the warlike activities bring instability to the international payment systems, investors will turn their attention back to precious metals. Gold was able to develop positive sentiment and make a clean turnaround last week. It landed back in the USD 1,945 to USD 1,965 resistance zone after the recent corrections around USD 1,890. With a dynamic breakout, it could now technically go back up to the USD 1,980 to USD 2,015 zone. It is worth paying close attention here because the nervousness in the markets remains immanent.

    Canadian explorer Ximen Mining Corp. (XIM) owns promising precious metals properties in British Columbia. Specifically, these are the Amelia gold mine and the Brett epithermal gold project and, by option, the Treasure Mountain silver project, which is adjacent to the formerly producing Huldra silver mine. Other claims relate to the Greenwood mining camp, the Kenville mine and other blocks in the Nelson area and near Cranbrook.

    In early April, the Company completed a private placement of 10 million units at CAD 0.15, plus a full warrant at CAD 0.25 for 24 months. The Company will use the net proceeds of just under CAD 1.5 million to pay for exploration of the projects and as general working capital. Initial results from drilling should be announced later this year. The good performance of the precious metals means that the valuation of Ximen's resources in the ground can be steadily increased. The 98.7 million XIM shares currently add up to a market capitalization of CAD 17.7 million. It is a good starting point for further appreciation.

    Bayer - Strong growth expected in the Crop Science segment

    There is no stopping Bayer shares at the moment. Due to the glyphosate scandal and the upheavals surrounding Monsanto, the stock has been trending steadily downward since 2017. However, the zone around EUR 45 offered a good limit for substantial recoveries each time in the last three correction movements. And in the last 2 weeks, there was now a strong breakout on the upside because Monsanto's agricultural division could become attractive in the current environment.

    However, the decisive factor for the good mood was the latest publications on the possible Xarelto successor asundexian. Bayer has made progress in the development of the new anticoagulant. A Phase IIb study showed a lower risk of bleeding in patients with atrial fibrillation and a high risk of stroke compared with the standard drug apixaban. Depending on the evaluation of the details, the pivotal Phase III trial is likely to start this year, a Group spokesman said. According to analyst Alistair Campbell of investment firm Liberum, if approved, the drug could be an even bigger success than the best-selling Xarelto, which generates billions in sales for Bayer every year.

    Analysts were, therefore, optimistic about the DAX share last week because of the expected blockbuster asundexian. JP Morgan, for example, is confident that Bayer shares will rise to EUR 75, with an "overweight" rating. At EUR 90, the UBS price target for the pharmaceutical giant from Leverkusen is even a good deal higher. The share continued to jubilate and is now heading for the EUR 70 mark. Stay invested with a stop at EUR 58.50.


    Due to the impairment of Ukrainian and Belarusian food exports, concerns about the world supply of wheat are constantly increasing. This draws attention to fertilizer and seed manufacturers and crop protection experts. K+S and Bayer have a lot to offer here. In the gold and silver sector, Ximen Mining is preparing to climb the next valuation levels.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.


    Der Autor

    André Will-Laudien

    Born in Munich, he first studied economics and graduated in business administration at the Ludwig-Maximilians-University in 1995. As he was involved with the stock market at a very early stage, he now has more than 30 years of experience in the capital markets.

    About the author



    Related comments:

    Commented by André Will-Laudien on April 15th, 2022 | 12:14 CEST

    Barrick Gold, Barsele Minerals, BASF - Investing in scarcity: 3 B-shares with potential

    • Gold
    • PreciousMetals

    The risks on the capital markets are increasing, as can be seen in the volatility indices. They were around 18 before the invasion of Ukraine and rose to over 35 by mid-March. The volatility index measures the range of fluctuation expected by the futures markets in the coming months. If we follow this indication, we could still be in for a tough summer. Possibly significantly lower again but, with the desired political easing, also a little upward similarly. However, investors need to be aware of the exploding inflation, the tight commodity markets and the supply chain problem. These are ongoing issues that will not pass anytime soon. The following values could provide some stability.

    Read

    Commented by Armin Schulz on April 9th, 2022 | 07:30 CEST

    Barrick Gold, Ximen Mining, First Majestic Silver - Do precious metal stocks belong in the portfolio now?

    • Gold
    • Silver
    • PreciousMetals

    Crises like the current Ukraine war or the steadily rising inflation are good for precious metals like gold and silver. According to the German Association for Precious Metals, demand for physical precious metals increased by at least 25% in the first three months of this year. Demand had already climbed by 31% last year. But not everyone can store precious metals safely. The alternative is to invest in precious metals companies listed on the stock exchange. We take a closer look at three candidates today.

    Read

    Commented by Nico Popp on November 17th, 2021 | 13:11 CET

    Barrick Gold, Triumph Gold, Newmont: Here is what matters for Barrick and Co.

    • PreciousMetals

    The gold price has recovered in recent weeks. The increasingly strong inflationary pressure and the growing nervousness of professional market participants, such as banks, which see increasing pressure on monetary guardians to act in the fight against inflation, may have attracted some investors' attention to the precious metal again. But how can investors invest? Physical holdings involve incidental purchase costs and require a safe deposit box - bank safe deposit boxes are already in short supply at present. Financial products, such as ETCs, are more paper than precious metal and are certainly not suitable for crisis protection in the worst case. That leaves equities. We present three stocks.

    Read